
Ralph Joseph Panos MD
Critical Care Medicine, Pleural Disease
Professor, Internal Medicine, University of Cincinnati College of Medicine
Join to view full profile
222 Piedmont AvenueSuite 4000Cincinnati, OH 45219
Phone+1 513-475-8523
Fax+1 513-475-7327
Dr. Panos is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1987 - 1990
University of MarylandResidency, Internal Medicine, 1983 - 1987
The Warren Alpert Medical School of Brown UniversityClass of 1983
Certifications & Licensure
OH State Medical License 2004 - 2028
PA State Medical License 1997 - 2004
IL State Medical License 1991 - 1999
CO State Medical License 1990 - 1993
MD State Medical License 1986 - 1987
American Board of Internal Medicine Internal Medicine
Clinical Trials
- Long-term Oxygen Treatment Trial
- Extended Steroid in Use in Community Acquired Pneumonia (CAP)(e) Start of enrollment: 2012 Jan 09
Publications & Presentations
PubMed
- 1 citationsProlonged Tele-Critical Care Utilization Is Associated With Improved ICU Outcomes: Evidence From Veterans Affairs Hospitals.Mohsen Nabian, Louis Atallah, Ludmila Brochini, Yesha Vora, Joshua Rubenfeld
Critical Care Medicine. 2025-11-01 - A portable oral positive expiratory pressure device effectively improves lung aeration and oxygenation in post-operative atelectasis.Aamir Munshi, Michael H Hellmann, Ihuoma Ogbuokiri, Rachel Baker, Ralph J Panos
Respiratory Medicine. 2025-11-01 - 4 citationsSupplementary oxygen efficacy for chronic pulmonary disorders and exertion desaturation.Paraschos Archontakis Barakakis, Adam Wolfe, Andrei Schwartz, Gabriel J Hernandez Romero, Vipul Gidwani
ERJ Open Research. 2024-11-01
Press Mentions
Arch Biopartners’ Therapy Candidate AB569 Receives US Patent for Treatment of Chronic Lung InfectionsApril 6th, 2018
Veterans Affairs Hospital Introduces New Tele-ICU TechnologyMarch 28th, 2018
Arch Biopartners’ Lead Anti-Bacterial Drug Candidate AB569 to Enter Investigator-Sponsored Phase I Human TrialApril 13th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: